BIOCHEMICAL-CHARACTERIZATION AND BIOLOGICAL EFFECTS OF PARTIALLY PURIFIED B-CELL-ACTIVATING FACTOR (BCAF)

被引:8
|
作者
ROTH, C
MOREAU, JL
KORNER, M
JANKOVIC, D
THEZE, J
机构
关键词
D O I
10.1002/eji.1830180414
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:577 / 584
页数:8
相关论文
共 50 条
  • [41] Correlation of B-cell-activating Factor Levels and Diseases Activity in Systemic Lupus Erythematosus Patients
    Vitri, Ria Yolanda
    Wachjudi, Rachmat Gunadi
    Ghassani, Nadia Gita
    Hamijoyo, Laniyati
    INDIAN JOURNAL OF RHEUMATOLOGY, 2021, 16 (01) : 13 - 17
  • [42] CHARACTERIZATION OF PARTIALLY PURIFIED GROUP-B STREPTOCOCCAL CLUMPING FACTOR
    USUI, Y
    YOSHIDA, K
    SANCLEMENTE, CL
    ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1982, 252 (03): : 299 - 309
  • [43] B-cell-activating factor (BAFF) and platelet-activating factor (PAF) in pregnancies complicated by maternal obesity and diabetes: a preliminary study
    Neri, Caterina
    Ciliberti, Alessandra
    Dessi, Davide Archelao
    Airoldi, Chiara
    Basello, Katia
    Costanzi, Andrea
    Familiari, Alessandra
    Tersigni, Chiara
    Cappelletti, Mattia
    Speciani, Attilio Francesco
    Lanzone, Antonio
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2023, 36 (02):
  • [44] Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis
    Thangarajh, M
    Gomes, A
    Masterman, T
    Hillert, J
    Hjelmström, P
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 152 (1-2) : 183 - 190
  • [45] RETREATMENT WITH RITUXIMAB IN ANTI-MAG POLYNEUROPATHY: IS THE B-CELL-ACTIVATING FACTOR (BAFF) A NEGATIVE PROGNOSTIC FACTOR?
    Garnero, M.
    Franciotta, D.
    Briani, C.
    Campagnolo, M.
    Grandis, M.
    Fabbri, S.
    Beronio, A.
    Mancardi, G. L.
    Schenone, A.
    Benedetti, L.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 : S19 - S19
  • [46] BIOCHEMICAL-CHARACTERIZATION OF A B-CELL GROWTH-FACTOR DISTINCT FROM INTERLEUKIN-2
    FARRAR, JJ
    HOWARD, M
    HILFIKER, ML
    BENJAMIN, WR
    FULLERFARRAR, J
    PAUL, WE
    CELLULAR IMMUNOLOGY, 1982, 70 (02) : 386 - 386
  • [47] B-cell-activating factor in rituximab-treated patients with anti-MAG polyneuropathy
    Benedetti, Luana
    Zardini, Elisabetta
    Briani, Chiara
    Beronio, Alessandro
    Gastaldi, Stefania
    Jarius, Sven
    Mancardi, Gian Luigi
    Schenone, Angelo
    Franciotta, Diego
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (11): : 1291 - 1294
  • [48] BIOLOGICAL AND BIOCHEMICAL-CHARACTERIZATION OF MACROPHAGE ACTIVATING FACTOR (MAF) IN MURINE LYMPHOCYTES - PHYSICOCHEMICAL SIMILARITY OF MAF TO GAMMA INTERFERON (IFN-GAMMA)
    FUKAZAWA, Y
    KAGAYA, K
    MIURA, H
    SHINODA, T
    NATORI, K
    YAMAZAKI, S
    MICROBIOLOGY AND IMMUNOLOGY, 1984, 28 (06) : 691 - 702
  • [49] Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice
    Ding, Hanlu
    Wang, Li
    Wu, Xiongfei
    Yan, Jun
    He, Yani
    Ni, Bing
    Gao, Wenda
    Zhong, Xuemei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (6B) : 1717 - 1725
  • [50] BIOCHEMICAL-CHARACTERIZATION OF THE STIMULATORY EFFECTS OF HALOTHANE AND PROPOFOL ON PURIFIED BRAIN PROTEIN-KINASE-C
    HEMMINGS, HC
    ADAMO, AIB
    HOFFMAN, MM
    ANESTHESIA AND ANALGESIA, 1995, 81 (06): : 1216 - 1222